|
|
|
|
| LEADER |
01379nam a2200277 a 4500 |
| 001 |
1838828 |
| 005 |
20171111234622.0 |
| 008 |
110408s2011 dcua sb 100 0 eng d |
| 020 |
|
|
|z 9780309161824
|
| 040 |
|
|
|a CaPaEBR
|z 0309161827
|
| 050 |
1 |
4 |
|a RM301.3.G45
|b I57 2011eb
|
| 110 |
2 |
|
|a Institute of Medicine (U.S.)
|
| 245 |
1 |
0 |
|a Establishing precompetitive collaborations to stimulate genomics-driven product development
|b workshop summary /
|c Institute of Medicine of the National Academies ; Steve Olson and Adam C. Berger, rapporteurs.
|
| 260 |
|
|
|a Washington, D.C. :
|b National Academies Press,
|c 2011.
|
| 300 |
|
|
|a xv, 74 p. :
|b ill. (some col.)
|
| 500 |
|
|
|a "Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy."
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 650 |
|
0 |
|a Pharmacogenetics
|
| 650 |
|
0 |
|a Drug development
|
| 700 |
1 |
|
|a Olsen, Steven.
|
| 700 |
1 |
|
|a Berger, Adam C.
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Roundtable on Translating Genomic-Based Research for Health.
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Board on Health Sciences Policy.
|
| 711 |
2 |
|
|a Establishing Precompetitive Collaborations to stimulate genomics-driven product development
|c Washington, D.C.)
|d (2010 :
|
| 856 |
4 |
0 |
|u http://site.ebrary.com/lib/ucy/Doc?id=10454959
|
| 952 |
|
|
|a CY-NiOUC
|b 5a045e7c6c5ad14ac1edd1dd
|c 998a
|d 945l
|e -
|t 1
|x m
|z Books
|
